Online Therapy for Gynecologic Cancer
(eSense-Cancer Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how an online therapy program can address the sexual health needs of gynecologic cancer survivors. It tests two types of therapy: eSense-Cancer CBT (Cognitive Behavioral Therapy) and eSense-Cancer MBT (Mindfulness-Based Therapy), offered with or without a "navigator" (a support person). The goal is to determine if this online platform can assist survivors who live far away or face other obstacles to receiving treatment. Individuals who have had gynecologic cancer, experience sexual difficulties, and have internet access may be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve access to care for many survivors.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, if you are in active treatment for cancer, you would not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT) are generally safe and well-tolerated. These therapies improve sexual health and well-being.
The eSense-Cancer program offers these therapies online. Although specific data on side effects for the online version is unavailable, these therapies have proven safe in other settings, so similar results are expected online.
As the eSense-Cancer program is neither a medication nor a surgical treatment, the risk of side effects is much lower. This makes it a safe option for those seeking to improve sexual health after gynecologic cancer.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because eSense-Cancer CBT and MBT offer innovative online therapy options for individuals with gynecologic cancer. Unlike traditional in-person therapy, these digital platforms provide cognitive behavioral therapy (CBT) and mindfulness-based therapy (MBT) that can be accessed remotely, making it more convenient and accessible. A unique feature of this trial is the inclusion of a "navigator" who can support participants through the therapy, potentially enhancing the effectiveness of the treatment. This approach could redefine how psychological support is provided to cancer patients, offering personalized, flexible, and potentially more engaging mental health care solutions.
What evidence suggests that this trial's treatments could be effective for gynecologic cancer survivors?
This trial will compare the effectiveness of cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT) in improving sexual health and well-being in women who have survived gynecologic cancer. Participants will be assigned to one of the treatment arms, either with or without support from a treatment "navigator." Research has shown that both CBT and MBT can improve emotional well-being and comfort in discussing sensitive issues. The benefits of these therapies have been observed to last even three months after the sessions ended. Both CBT and MBT have enhanced the overall quality of life for cancer survivors. These therapies are available online, making them more accessible for those who live far away or face other challenges in reaching treatment.24567
Who Is on the Research Team?
Lori A Brotto, PhD, RPsych
Principal Investigator
University of British Columbia
Kyle Stephenson, PhD, RPsych
Principal Investigator
Xavier University of Louisiana.
Are You a Good Fit for This Trial?
This trial is for individuals with a history of any gynecologic cancer who are experiencing sexual health concerns. Participants must be fluent in English, able to commit to an 8-16 week program, have reliable internet access, and be comfortable using online platforms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires and undergo a 4-week waiting period before a second baseline assessment
Treatment
Participants are randomized to one of four arms and complete 8 modules of CBT or MBT with or without navigator support
Post-Treatment Assessment
Participants complete post-treatment questionnaires to assess various feasibility dimensions and clinical outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- eSense-Cancer CBT
- eSense-Cancer MBT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Xavier University of Louisiana.
Collaborator